October 13, 2024 — We are witnessing quite a number of battles unfolding and harming innocent people in diverse settings. They range from actual wars to political contests to the lucrative business of healthcare. A common thread in all of these situations is shamelessness in pursuing money, power, or both. That shamelessness is especially troubling when it pops up […]
November 13, 2023 — Nestled in the midst of a lot of good news last week was a nasty reminder of a persistent problem. It’s the fake line that people persist in drawing between obesity and other metabolic disease. Lilly did it (with consent from FDA) when they decided to put a different brand name on tirzepatide for obesity. […]
July 1, 2023 — The news arrived in our inbox yesterday. Drug shortages that have plagued semaglutide and tirzepatide are growing worse, not fading. Novo Nordisk quietly let the word out: those supply shortages are no longer limited to Ozempic and Wegovy. Saxenda is entering a prolonged period of shortage. So it now appears that constrained supply, high prices, […]
